First Cure Case of 2019 Novel Coronavirus in Ningxia, China

Introduction

Case Summary

A 28-year-old male, returning from Wuhan, was admitted to the hospital with symptoms including fever, occasional cough, and headache. Laboratory tests, real-time reverse transcriptase polymerase chain reaction (RT-PCR), and chest CT scans confirmed the diagnosis of COVID-19 pneumonia. Key findings included:

  • Elevated body temperature (38.5°C)
  • Lung abnormalities detected via CT scans
  • Positive RT-PCR results for COVID-19

Treatment and Recovery

The patient underwent a 14-day antiviral therapy regimen, which included:

  • Moxifloxacin (0.4g IV per day)
  • Lopinavir/ritonavir (400/100mg orally every 12 hours)
  • Interferon inhalation (5 million IU every 12 hours)

After treatment, follow-up chest CT scans showed a significant reduction in lung opacities, and consecutive negative RT-PCR results confirmed recovery. The patient was discharged and advised to continue home isolation for 14 days.

Broader Implications in Radiology

Full Study Reference

Conclusion

This case underscores the effectiveness of early diagnosis, targeted therapy, and continuous monitoring in treating COVID-19. Future research will further enhance treatment protocols and patient outcomes.

Disclaimer: This content is generated using AI assistance and should be reviewed for accuracy and compliance before considering this article and its contents as a reference. Any mishaps or grievances raised due to the reusing of this material will not be handled by the author of this article.

You may provide us with feedback in the comments section.